Challoumas, D., Kirwan, P. D., Borysov, D., Clifford, C., McLean, M. and Millar, N. L. (2019) Topical glyceryl trinitrate for the treatment of tendinopathies: a systematic review. British Journal of Sports Medicine, 53(4), pp. 251-262. (doi: 10.1136/bjsports-2018-099552) (PMID:30301735) (PMCID:PMC6362607)
|
Text
167519.pdf - Published Version Available under License Creative Commons Attribution. 885kB |
Abstract
Objective: To produce a best evidence synthesis of the clinical effects of topical glyceryl trinitrate (GTN) in the treatment of tendinopathies. Design: A systematic review of published randomised controlled trials (RCTs) of the use of GTN in patients with tendinopathy. Data sources: MEDLINE, Embase, Scopus and CINAHL from database inception to January 2018. Methods: We examined RCTs comparing the effects of topical GTN with either placebo or other treatments on tendinopathy. Overall quality of each eligible study was determined based on a combined assessment of internal validity, external validity and precision. The level of evidence for each assessed parameter was rated based on the system by van Tulder et al. Results: A total of 10 eligible RCTs were identified including patients with tendinopathy of the rotator cuff (n=4), wrist extensors (n=3), Achilles (n=2) and patellar (n=1) tendons. For all tendinopathies, improvements in pain were significant when comparing GTN versus placebo in the short term (<8 weeks; poor evidence). Significant improvements in midterm outcomes for treatment with GTN versus placebo included the following: patient satisfaction (strong evidence); chances of being asymptomatic with activities of daily living (strong evidence); range of movement (moderate evidence); strength (moderate evidence); pain (at night and with activity; poor evidence) and local tenderness (poor evidence). Patients treated with topical GTN reported a higher incidence of headaches than those who received placebo (moderate evidence). Conclusions and relevance: Treatment of tendinopathies with topical GTN for up to 6 months appears to be superior to placebo and may therefore be a useful adjunct to the treating healthcare professions.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | McLean, Michael and Challoumas, Mr Dimitris and Millar, Professor Neal |
| Authors: | Challoumas, D., Kirwan, P. D., Borysov, D., Clifford, C., McLean, M., and Millar, N. L. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing |
| Research Centre: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Immunobiology |
| Journal Name: | British Journal of Sports Medicine |
| Publisher: | BMJ Publishing Group |
| ISSN: | 0306-3674 |
| ISSN (Online): | 1473-0480 |
| Published Online: | 09 October 2018 |
| Copyright Holders: | Copyright © 2018 The Authors |
| First Published: | First published in British Journal of Sports Medicine 53(4): 251-262 |
| Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record
Funder and Project Information
Funder and Project Information